Cafepharma Today

May 19 2025 - Regeneron wins bid to buy 23andMe out of bankruptcy
Regeneron wins bid to buy 23andMe out of bankruptcy
Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant
Japan follows UK in GSK's comeback tour for Blenrep
FDA clears Novavax’s COVID-19 vaccine with usage restrictions
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What Should Merck Do With Its $14 Billion Windfall?
Motley Fool
Wednesday, May 7, 2014 - 9:51am
tags:
Merck, Bayer, restructuring
Pfizer Has Cameron Channeling Hollande Amid Job Fears
Bloomberg
Wednesday, May 7, 2014 - 9:50am
tags:
Pfizer, UK, AstraZeneca
Corcept Therapeutics stops depression drug trial
Yahoo/AP
Wednesday, May 7, 2014 - 9:48am
tags:
Corcept Therapeutics, depression, psychotic depression
Aegerion's Rare Disease Drug Launch Stalls
TheStreet.com
Wednesday, May 7, 2014 - 8:58am
tags:
Aegerion, drug launches, Juxtapid, earnings
Meda CEO says company could double size in two years
Reuters
Wednesday, May 7, 2014 - 8:31am
tags:
Meda, Mylan Labs, M&A
New Ernst & Young Report Promotes 'Radical Collaboration' For Pharma 3.0
Forbes
Wednesday, May 7, 2014 - 8:30am
tags:
social media, insurance
Women's health: Boston Scientific nabs the rest of IoGyn for $65M
Mass Device
Wednesday, May 7, 2014 - 8:27am
tags:
Boston Scientific, devices, IoGyn, Women's Health
Loxo lands $24M venture round and a CSO for cancer drug research
Fierce Biotech
Wednesday, May 7, 2014 - 8:24am
tags:
Loxo Oncology, CSO, R&D, cancer
Discovery Labs Expands Exclusivity Portfolio with Three New US Patents
Yahoo
Wednesday, May 7, 2014 - 8:20am
tags:
Discovery Labs, patents
Cancer Doctors Join Insurers in U.S. Drug-Cost Revolt
Bloomberg
Wednesday, May 7, 2014 - 8:17am
tags:
physicians, drug costs, Gilead Sciences, Sovaldi, cancer
Merck’s Big Deal May Not Beget Another, Frazier Insists
Bloomberg
Wednesday, May 7, 2014 - 8:16am
tags:
Merck, Kenneth Frazier, M&A, Bayer
Pfizer says AstraZeneca takeover would benefit science
Yahoo/Reuters
Wednesday, May 7, 2014 - 8:14am
tags:
Pfizer, M&A, AstraZeneca
AstraZeneca in partnering talks for Alzheimer drug
Yahoo/Reuters
Wednesday, May 7, 2014 - 8:13am
tags:
Alzheimer's disease, AstraZeneca, BACE inhibitors
Bayer’s $14.2 Billion Merck Buy Exposes Strategy Split
Bloomberg
Tuesday, May 6, 2014 - 7:58pm
tags:
Bayer, Merck, M&A, consumer health
Theravance Unveils Separation Plans and Initiates Dividend As Q1 Loss Widens 81%
Motley Fool
Tuesday, May 6, 2014 - 7:56pm
tags:
earnings, Theravance
Blood-Pressure Drug With Thousands of Complaints Draws FDA Test
Bloomberg
Tuesday, May 6, 2014 - 4:59pm
tags:
FDA, hypertension, AstraZeneca, Toprol XL
Teva starts process to close 15% of its production sites
Fierce Pharma
Tuesday, May 6, 2014 - 4:54pm
tags:
Teva Pharmaceuticals, drug manufacturing
Will Arena Seize An Opportunity?
Seeking Alpha
Tuesday, May 6, 2014 - 4:46pm
tags:
Arena Pharmaceuticals, Vivus, Orexigen, Belviq, obesity, Qsymia
Merck: New drugs pending approval or in late tests
Yahoo/AP
Tuesday, May 6, 2014 - 4:43pm
tags:
Merck, approvals
Can Bristol-Myers Squibb Make a Comeback in 2014?
Motley Fool
Tuesday, May 6, 2014 - 4:38pm
tags:
Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.